现代妇女(医学前沿)
現代婦女(醫學前沿)
현대부녀(의학전연)
Modern Women(Frontiers of Medicine)
2014年
11期
25-26
,共2页
避孕药%二甲双胍%多囊卵巢综合症%临床疗效%治疗组%对照组
避孕藥%二甲雙胍%多囊卵巢綜閤癥%臨床療效%治療組%對照組
피잉약%이갑쌍고%다낭란소종합증%림상료효%치료조%대조조
the pill%metformin polycystic%ovary syndrome clinical%curative effect of the treatment%group and control group
目的:探讨与分析口服避孕药、二甲双胍联合治疗多囊卵巢综合症的临床疗效以及其应用价值。方法选择2013年1月~2014年3月来我院接受治疗患有多囊卵巢综合症患者76例作为研究对象,由于这些患者之间没有显著性差异,具有可比性,P>0.05,因此,本研究将这些患者进行随机分组,即治疗组(34例)与对照组(32例),本研究对治疗组患者给予口服避孕药+二甲双胍药物治疗方案进行治疗,而对对照组患者只给予口服避孕药物治疗方案进行治疗,以观察两组患者的临床疗效以及临床各项指标情况。结果通过对两组患者给予不同治疗方案进行治疗后,治疗组患者的临床总有效率(97.1%)高于对照组患者的临床总有效率(81.3%),另外,治疗组患者的临床各项指标情况优于对照组患者的临床各项指标,由此可以看出,两组患者之间存在显著性差异,具有统计学意义。结论通过本研究结果得知,治疗组患者在口服避孕药+二甲双胍联合治疗方案背景下得到良好的临床效果,并且其临床效果优于对照组患者的临床效果,另外,治疗组患者的临床各项指标情况优于对照组患者的临床各项指标,因此,口服避孕药联合二甲双胍治疗方案值得在多囊卵巢综合症临床活动中值得推广与应用,从而为广大患者带来福音。
目的:探討與分析口服避孕藥、二甲雙胍聯閤治療多囊卵巢綜閤癥的臨床療效以及其應用價值。方法選擇2013年1月~2014年3月來我院接受治療患有多囊卵巢綜閤癥患者76例作為研究對象,由于這些患者之間沒有顯著性差異,具有可比性,P>0.05,因此,本研究將這些患者進行隨機分組,即治療組(34例)與對照組(32例),本研究對治療組患者給予口服避孕藥+二甲雙胍藥物治療方案進行治療,而對對照組患者隻給予口服避孕藥物治療方案進行治療,以觀察兩組患者的臨床療效以及臨床各項指標情況。結果通過對兩組患者給予不同治療方案進行治療後,治療組患者的臨床總有效率(97.1%)高于對照組患者的臨床總有效率(81.3%),另外,治療組患者的臨床各項指標情況優于對照組患者的臨床各項指標,由此可以看齣,兩組患者之間存在顯著性差異,具有統計學意義。結論通過本研究結果得知,治療組患者在口服避孕藥+二甲雙胍聯閤治療方案揹景下得到良好的臨床效果,併且其臨床效果優于對照組患者的臨床效果,另外,治療組患者的臨床各項指標情況優于對照組患者的臨床各項指標,因此,口服避孕藥聯閤二甲雙胍治療方案值得在多囊卵巢綜閤癥臨床活動中值得推廣與應用,從而為廣大患者帶來福音。
목적:탐토여분석구복피잉약、이갑쌍고연합치료다낭란소종합증적림상료효이급기응용개치。방법선택2013년1월~2014년3월래아원접수치료환유다낭란소종합증환자76례작위연구대상,유우저사환자지간몰유현저성차이,구유가비성,P>0.05,인차,본연구장저사환자진행수궤분조,즉치료조(34례)여대조조(32례),본연구대치료조환자급여구복피잉약+이갑쌍고약물치료방안진행치료,이대대조조환자지급여구복피잉약물치료방안진행치료,이관찰량조환자적림상료효이급림상각항지표정황。결과통과대량조환자급여불동치료방안진행치료후,치료조환자적림상총유효솔(97.1%)고우대조조환자적림상총유효솔(81.3%),령외,치료조환자적림상각항지표정황우우대조조환자적림상각항지표,유차가이간출,량조환자지간존재현저성차이,구유통계학의의。결론통과본연구결과득지,치료조환자재구복피잉약+이갑쌍고연합치료방안배경하득도량호적림상효과,병차기림상효과우우대조조환자적림상효과,령외,치료조환자적림상각항지표정황우우대조조환자적림상각항지표,인차,구복피잉약연합이갑쌍고치료방안치득재다낭란소종합증림상활동중치득추엄여응용,종이위엄대환자대래복음。
Objective: To investigate the clinical effect and analysis of oral contraceptives, metformin in treatment of polycystic ovarian syn-drome and its application value. Methods:in 2013 January~2014 year in March in our hospital treated 76 cases of polycystic ovary syndrome patients as the research object, because there is no significant difference between these patients and comparable, P > 0.05. Therefore, this study will these patients were randomly divided into two groups, namely treatment group (34 cases) and the control group (32 cases), this study for the treatment of the patients in the treatment group were given oral contraceptives + metformin drug treatment programs, and the control group was treated only with oral contraceptive drug regimens for treatment, to observe the clinical efficacy of two groups of patients and the clinical various indexes. Results:the patients in the two group received different treatment options for patients in the treatment group after treatment, the clinical total effective rate (97.1%) was higher than that in the control group the total effective rate of clinical patients (81.3%), in addition, the clinical indexes of patients in the treatment group were superior to the control group of patients with clinical indica-tors, thus it can be seen that the existence of significant differences between the two groups was statistically significant. Conclusion: the result of this study is that patients in the treatment group oral contraceptives and metformin therapy scheme background obtained good clinical ef-fect, and its clinical effect was better than that of the control group of patients with clinical effect, in addition, the clinical indexes of patients in the treatment group were superior to that in the control group of patients with clinical indicators, therefore, combined with metformin treat-ment scheme oral contraceptives is worthy to be extended and applied in polycystic ovary syndrome clinical activities, so as to bring the gospel to the majority of patients.